<DOC>
	<DOCNO>NCT01546688</DOCNO>
	<brief_summary>A two arm , randomize , double-blind study compare zonisamide placebo . The zonisamide arm consist 100 subject placebo arm 50 subject . Study medication administer add-on treatment subject 's current 1 2 anti-epileptic ( AEDs ) .</brief_summary>
	<brief_title>A Study Evaluate Safety Tolerability Explore Efficacy Zonisamide add-on Therapy Elderly Patients With Refractory Partial Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Zonisamide</mesh_term>
	<criteria>Key 1 . Capable maintaining seizure daily diary access caregiver prepare complete patient 's behalf . 2 . Able complete questionnaire use study . 3 . Localization related epilepsy , simple and/or complex partial seizure without secondary generalized seizure define International League Against Epilepsy ( ILAE ) criterion . 4 . Have least one well documented seizure 4 week precede Randomisation Visit ( Visit 2 ) deem require additional AED medication . 5 . Receiving least one , two market AEDs concomitant medication , dosage stable least four week Screening Visit . Key 1 . Seizures attribute metabolic cause ( e.g. , electrolyte disturbance , hyperglycaemia ) . 2 . Seizures could attribute use drug . 3 . Presence primary generalise epilepsy seizure , absence , myoclonic epilepsy , LennoxGastaut syndrome . 4 . A history eat disorder body weight 40 kg . 5 . A history blood dyscrasia . 6 . A history renal stone risk factor nephrolithiasis family history nephrolithiasis hypercalciuria . 7 . An increase risk factor rhabdomyolysis uncontrolled hypothyroidism , personal family history muscle disorder . 8 . Taking concomitant medication associate nephrolithiasis medication increase risk rhabdomyolysis . 9 . Taking rifampicin drug anticholinergic effect . 10 . Taking carbonic anhydrase inhibitor topiramate . 11 . A history pancreatitis . 12 . A history Stevens Johnson Syndrome . 13 . Elevated level serum creatinine &gt; 165 Umol , know severe hepatic impairment extent protocol dose titration schedule follow .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>